KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomarin Pharmaceutical (BMRN) Investment Income: 2009

Historic Investment Income for Biomarin Pharmaceutical (BMRN) over the last 1 years, with Dec 2009 value amounting to $5,000.

  • Biomarin Pharmaceutical's Investment Income was N/A to -$3,000 in Q1 2010 from the same period last year, while for Dec 2009 it was -$12.0 million, marking a year-over-year change of. This contributed to the annual value of $5,000 for FY2009, which is N/A change from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Investment Income of $5,000 as of FY2009.
  • In the past 5 years, Biomarin Pharmaceutical's Investment Income registered a high of $5,000 during FY2009, and its lowest value of $5,000 during FY2009.
  • In the last 1 years, Biomarin Pharmaceutical's Investment Income had a median value of $5,000 in 2009 and averaged $5,000.